Biotech companies have always licensed programs, but never so many from one region in particular.

Crossover investors, asset managers, mutual funds and hedge funds are rebalancing their AI-heavy portfolios by creeping back ...

Another sector has called for a capital gains tax change carve-out, warning the government that it will face a talent drain ...

Discover the role of biotechnology in healthcare, medicine, and investment. Understand biotech processes, top companies, and ...

Biotech is producing scientific breakthroughs that once seemed impossible. But according to longtime industry executive Jeremy Levin, the institutions ...

As large biopharma companies have increasingly turned to China for novel biotech innovation, political calls in the U.S. to ...

Expense ratios, yield, and sector breadth set these healthcare ETFs apart—see how their risk profiles and portfolio strategies compare.

Biotech is increasingly financed, governed and regulated as though it were a mature pharmaceutical industry rather than a ...

Nasdaq has long been the home for biotech companies, and this past January, National Biotechnology Month proved no different. The sector was active with five healthcare companies raising $800 million ...

Biotech stocks are attracting investors as M&A activity, valuations and upcoming catalysts help drive sector momentum.

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...